Activation of Aryl Hydrocarbon Receptor Suppresses Invasion of Esophageal Squamous Cell Carcinoma Cell Lines

Matsushima K. , Isomoto H. , Kohno S. , Nakao K. : MicroRNAs and esophageal squamous cell carcinoma. Digestion, 82: 138–144, 2010.

Li L. , Zhang C. , Li X. , Lu S. , Zhou Y. : The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. J Exp Clin Cancer Res, 29: 133, 2010. [THIS ARTICLE HAS BEEN RETRACTED, see http://www.jeccr.com/content/30/1/19]

Schuchert M.J. , Luketich J.D. , Landreneau R.J. : Management of esophageal cancer. Curr Probl Surg, 47: 845–946, 2010.

Hernández-Ochoa I. , Karman B.N. , Flaws J.A. : The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol, 77: 547–559, 2009.

Stevens E.A. , Mezrich J.D. , Bradfield C.A. : The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology, 127: 299–311, 2009.

Barouki R. , Coumoul X. , Fernandez-Salguero P.M. : The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett, 581: 3608–3615, 2007.

Rowlands J.C. , Gustafsson J.A. : Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol, 27: 109–134, 1997.

Stejskalova L. , Dvorak Z. , Pavek P. : Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr Drug Metab, 12: 198–212, 2011.

Lin P. , Chang H. , Tsai W.T. , Wu M.H. , Liao Y.S. , Chen J.T. , Su J.M. : Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol Pathol, 31: 22–30, 2003.

Wong P.S. , Li W. , Vogel C.F. , Matsumura F. : Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR). BMC Cancer, 9: 234, 2009.

Villano C.M. , Murphy K.A. , Akintobi A. , White L.A. : 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol, 210: 212–224, 2006.

Shimba S. , Komiyama K. , Moro I. , Tezuka M. : Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells. J Biochem, 132: 795–802, 2002.

Gluschnaider U. , Hidas G. , Cojocaru G. , Yutkin V. , Ben-Neriah Y. , Pikarsky E. : beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor. PLoS One, 5: e9060, 2010.

Ma Q. , Whitlock J.P. Jr. : The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol, 16: 2144–2150, 1996.

Fan Y. , Boivin G.P. , Knudsen E.S. , Nebert D.W. , Xia Y. , Puga A. : The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res, 70: 212–220, 2010.

Shi L.Z. , Czuprynski C.J. : Beta-naphthoflavone causes an AhR-independent inhibition of invasion and intracellular multiplication of Listeria monocytogenes in murine hepatocytes. Microb Pathog, 47: 258–266, 2009.

Zatloukalová J. , Svihálková-Sindlerová L. , Kozubík A. , Krcmár P. , Machala M. , Vondrácek J. : beta-Naphthoflavone and 3′-methoxy-4′-nitroflavone exert ambiguous effects on Ah receptor dependent cell proliferation and gene expression in rat liver ‘stem-like’ cells. Biochem Pharmacol, 73: 1622–1634, 2007.

Brauze D. , Widerak M. , Cwykiel J. , Szyfter K. , Baer-Dubowska W. : The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. Toxicol Lett, 167: 212–220, 2006.

Clapp R.W. , Jacobs M.M. , Loechler E.L. : Environmental and occupational causes of cancer: new evidence 2005–2007. Rev Environ Health, 23: 1–37, 2008.

Nebert D.W. , Dalton T.P. , Okey A.B. , Gonzalez F.J. : Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem, 279: 23847–23850, 2004.

Hall J.M. , Barhoover M.A. , Kazmin D. , McDonnell D.P. , Greenlee W.F. , Thomas R.S. : Activation of the arylhydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol, 24: 359–369, 2010.

Koliopanos A. , Kleeff J. , Xiao Y. , Safe S. , Zimmermann A. , Büchler M.W. , Friess H. : Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene, 21: 6059–6070, 2002.

Wormke M. , Castro-Rivera E. , Chen I. , Safe S. : Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. J Steroid Biochem Mol Biol, 72: 197–207, 2000.

Peng T.L. , Chen J. , Mao W. , Song X. , Chen M.H. : Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol, 10: 27, 2009.

Ishida M. , Mikami S. , Kikuchi E. , Kosaka T. , Miyajima A. , Nakagawa K. , Mukai M. , Okada Y. , Oya M. : Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Carcinogenesis, 31: 287–295, 2010.